Safety of a new deworming pill for children in Ghana and Kenya
Part of Infections clinical trials.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 17 years old.
- You are taller than 110 cm (about 3 feet 7 inches).
- A parent or guardian agrees to let you join and signs a form.
- You have not traveled to certain countries in Africa where a different parasite (Loa loa) is common.
- You do not have a serious illness like high fever, severe diarrhea, or brain symptoms.
- You are not allergic to any ingredient in the study pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
This study tests new combinations of deworming medicines to treat whipworm infection in school-aged children in Honduras. It aims to find a more effective treatment for children with this parasitic infection.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This trial tests if albendazole can lower the number of Loa Loa worms (microfilariae) in your blood. You will take a pill daily for 21 days, and researchers will monitor how well it works and how safe it is.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
Hear when a new Soil-Transmitted Helminths trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.